Speakers

The following are among those confirmed for the TTS North America 2017.

Check back weekly for updates.

  • Jay McGillSenior Director, Science & Technology Partnerships, Lilly & Co
  • Mark RohrbaughSpecial Advisor to the Director, Technology Transfer, NIH
  • Rich BendisPresident & CEO, BioHealth Innovation
  • Charles Baltic – Managing Director, Needham&Co
  • Maarten deJongManaging Director, Moelis Capital Partners
  • Carlo RizzutoPartner, Versant Ventures
  • Peter ReikesVice Chairman of Healthcare Investment, Stifel Nicolaus Weise
  • Jason AkusSVP Research, Tekla Capital Management
  • Erik LiumSenior Vice President, Mount Sinai Innovation Partners
  • Thomas LipkinHead of New Ventures, UCLA Technology Development Group, UCLA
  • Anne LaneDirector, Technology Transfer, University College London Business (UCLB), UK
  • Ofra WeinbergerDirector of Licensing, Columbia Technology Ventures; Columbia University
  • Alice Li – Executive Director, Technology Licensing, Weill Cornell Medicine
  • Brian KellyDirector, Technology Transfer, Weill Cornell Medicine
  • Tingting Zhang-KharasSenior Director, External Innovation Oncology, NYC, Lilly & Co
  • Sally ShorthosePartner, Bird&Bird
  • Kevin Noonan Partner, MBHB; Editor & Co-Founder, Patentdocs
  • Ron NewboldVP, External Research & Development. Pfizer
  • Jarrod BorkatSenior Director, Partnering & Strategy, Medimmune
  • Jeffery UlmerHead, Preclinical R&D, Vaccines, GSK
  • Vijayalakshmi AgnaniHead of Office, External Innovation, Strategy & Business Development, Sanofi US
  • Mitzi ConnersDirector of Licensing, Merck & Co
  • Chau KhuongPrivate Equity Partner, Orbimed Advisors
  • Debra EstrinAssociate Dean, Professor of Computer Science, Cornell Tech, NYC and Professor of Public Health, Weill Cornell Medical College
  • Jack PoAIMInd, Google

 

 
Awaiting confirmation:

  • Mid Atlantic Bio Angels group (MABA)– Representative tbc